SCHEDULE 13G: Significant Shareholder Reduces Stake in Adlai Nortye Ltd. Below 5%
Beneficial Ownership Report
Boary Investment Co. Ltd. and its affiliated entities have reduced their beneficial ownership in Adlai Nortye Ltd. to 4.79% through recent share sales, triggering a Schedule 13G filing.
Summary
- Boary Investment Co. Ltd. and its related entities (Suzhou Baoruiheng Venture Capital Partnership, Xiamen Biotime Biotechnology Co., Ltd., Xiamen Baotai Holding Group Co., Ltd., Xiamen WangChen Health Industry Co., Ltd., and Zhang Guofeng) have reported a beneficial ownership of 5,304,468 ordinary shares in Adlai Nortye Ltd.
- This stake represents 4.79% of Adlai Nortye Ltd.'s total outstanding ordinary shares, which were 110,700,805 as disclosed in the Issuer's annual report on Form 20-F filed on April 19, 2024.
- The reduction in ownership below the 5% threshold was primarily due to recent share sales by Boary Investment Co. Ltd.
- From December 11, 2023, to December 12, 2024, Boary Investment Co. Ltd. sold 25,134 American Depositary Shares (ADSs), equivalent to 75,402 ordinary shares, on the open market.
- Additionally, on April 22, 2025, Boary Investment Co. Ltd. executed a block trade, selling 380,000 ADSs (representing 1,140,000 ordinary shares) to an independent third party at a sale price of US$2.0 per ADS.
- The filing certifies that the securities were not acquired or held for the purpose of changing or influencing the control of Adlai Nortye Ltd.
Sentiment
Score: 5
Explanation: Neutral. This document is a factual disclosure of a change in beneficial ownership and does not provide information on the company's operational or financial performance. The reduction in stake by a significant holder is a factual event, not inherently positive or negative for the company's fundamentals.
Future Outlook
This document is a beneficial ownership report and does not contain any forward-looking statements or guidance from Adlai Nortye Ltd. or the reporting persons regarding the issuer's future performance or strategy.
Industry Context
This filing is a standard regulatory disclosure of a change in beneficial ownership, indicating that a significant investor has reduced their stake in Adlai Nortye Ltd. below the 5% threshold. Such filings are common when institutional investors adjust their portfolio positions and are not necessarily indicative of broader industry trends or specific company performance.
Stakeholder Impact
- Shareholders: The reduction in a significant shareholder's stake could be interpreted by the market as a signal regarding investor confidence or liquidity, potentially influencing trading activity.
Key Dates
| Date | Description |
|---|---|
| 10/03/2023 | Date of event which initially required the filing of this statement. |
| April 19, 2024 | Date of Adlai Nortye Ltd.'s annual report on Form 20-F, used for calculating total outstanding shares. |
| December 11, 2023 | Start date of open market sales of ADSs by Boary Investment Co. Ltd. |
| December 12, 2024 | End date of open market sales of ADSs by Boary Investment Co. Ltd. |
| April 22, 2025 | Date of block trade sale of 380,000 ADSs by Boary Investment Co. Ltd. |
| 04/29/2025 | Date of signing of the Schedule 13G filing. |
Keywords
Adlai Nortye Ltd., Schedule 13G, Beneficial Ownership, Shareholding, Boary Investment Co. Ltd., SEC Filing, Ordinary Shares, ADS, Block Trade, Institutional Investor, Share Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.